Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Welcome to the TNL Beta! We are actively improving this experience.

Share Feedback

Source study found

Story checked

Study shows opposite synaptic mechanisms cause identical cognitive deficits (opens in a new tab)

news-medical.net · 2026-11-05

Short answerEvidenceSource

Short answer

Not assessed

Check incomplete.

We found a likely source study, but its evidence could not be prepared for claim review. The article's claims remain unverified.

Share this check

Help improve NewsLink

Tell us what worked or what needs attention in this check.

Follow the evidence trail
1
2

NewsLink checks it

Source study identified.

A source study was identified, but the study's evidence could not be prepared for claim assessment. No claim verdicts are available.

View article claims
3
Source paper

Source layer

The 2 papers the story cites

Source study separated from background citations.

The research anchor for the report.

  • The study this story reportspresented as the new finding

    Opposing excitatory and inhibitory synaptic pathologies drive ZC4H2-associated intellectual disability

    Neuron · 2026

    Publisher (opens in a new tab)
  • Cited as backgroundpresented as earlier work

    The pathogenic factor of ZC4H2-associated rare disorder is a postsynaptic regulator for synaptic activity and cognitive function.

    Proceedings of the National Academy of Sciences of the United States of America · 2025

    PubMed (opens in a new tab)Full Tessa analysis (opens in a new tab)
Then inspect each claim

Evidence layer

Claim by claim

A source study was identified, but the study's evidence could not be prepared for claim assessment. The claims below have not been assessed.

Claim 1 of 6Not checkedThe team says different pathogenic mutations in the same gene can produce nearly identical cognitive deficits through diametrically opposite synaptic mechanisms.View evidenceHide evidence

As statednearly identical cognitive deficits

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Claim 2 of 6Not checkedA research team led by Dr. SHENG Nengyin of the Kunming Institute of Zoology reframed ZC4H2-associated rare disorder as a disease spectrum rather than a condition driven by a single mechanism.View evidenceHide evidence

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Claim 3 of 6Not checkedThe article says intervention should be guided by the specific mutation, rather than the diagnosis alone.View evidenceHide evidence

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Claim 4 of 6Not checkedIn the new study, the researchers identified two mutant classes: one lost AMPA receptor regulation, while another retained AMPA regulation but abnormally suppressed GABAA receptor subunits.View evidenceHide evidence

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Claim 5 of 6Not checkedTwo knock-in mouse models carrying representative patient mutations showed comparable cognitive deficits, including impaired novel-object recognition, social-memory loss, and defective spatial learning, without obvious motor or anxiety abnormalities.View evidenceHide evidence

As statedcomparable cognitive deficits

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Claim 6 of 6Not checkedThe article says muscimol restored inhibitory transmission and cognition in one mouse model, while perampanel had the opposite pattern of benefit across the two mutation models.View evidenceHide evidence

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Open the paper in Tessa

Opposing excitatory and inhibitory synaptic pathologies drive ZC4H2-associated intellectual disability

Neuron · 2026

Source record (opens in a new tab)

Why this one

Near certain

NewsLink found the paper. Tessa is where you inspect it deeply.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Europe PMC, Crossref · 16 candidate papers

Selected

Opposing excitatory and inhibitory synaptic pathologies drive ZC4H2-associated intellectual disability

Neuron · 2026 · Crossref

Source (opens in a new tab)
CandidateOpen access

The pathogenic factor of ZC4H2-associated rare disorder is a postsynaptic regulator for synaptic activity and cognitive function.

Proceedings of the National Academy of Sciences of the United States of America · 2025 · PubMed, Europe PMC

Tessa (opens in a new tab)Source (opens in a new tab)

And 10 more candidates considered.